home / stock / mgen / mgen short
Short Information | Miragen Therapeutics Inc. (NASDAQ:MGEN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 332,371 |
Total Actual Volume | 1,932,591 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 16,619 |
Average Short Percentage | 15.52% |
Is there a MGEN Short Squeeze or Breakout about to happen?
See the MGEN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
01-19-2021 | $23.29 | $23.01 | $23.9 | $22.9701 | 44,316 | 5,472 | 12.35% |
01-15-2021 | $25.08 | $23.03 | $25.08 | $22.3 | 88,393 | 17,287 | 19.56% |
01-14-2021 | $22.37 | $24.93 | $25.67 | $22 | 143,500 | 28,986 | 20.2% |
01-13-2021 | $22.76 | $22.3 | $23.01 | $21.82 | 71,452 | 12,215 | 17.1% |
01-12-2021 | $22 | $22.27 | $23.6699 | $21.5 | 149,027 | 28,542 | 19.15% |
01-11-2021 | $19.4465 | $21.93 | $23.9 | $19.4465 | 383,912 | 71,042 | 18.5% |
01-08-2021 | $18.06 | $18.79 | $20.98 | $17.95 | 355,676 | 66,834 | 18.79% |
01-07-2021 | $16.98 | $18.4 | $18.45 | $16.683 | 102,011 | 12,026 | 11.79% |
01-06-2021 | $16.64 | $16.51 | $17.2 | $16.39 | 54,645 | 10,263 | 18.78% |
01-05-2021 | $17.02 | $16.69 | $17.02 | $16.51 | 29,171 | 8,700 | 29.82% |
01-04-2021 | $16.45 | $17.2 | $17.29 | $16.1 | 46,194 | 2,112 | 4.57% |
12-31-2020 | $19 | $16.45 | $19.16 | $16.45 | 60,935 | 10,600 | 17.4% |
12-30-2020 | $16.32 | $16.8 | $16.975 | $16.22 | 19,653 | 4,091 | 20.82% |
12-29-2020 | $16.98 | $16.36 | $16.98 | $16.025 | 49,998 | 6,208 | 12.42% |
12-28-2020 | $17.63 | $17.12 | $17.63 | $16.72 | 49,090 | 7,434 | 15.14% |
12-24-2020 | $18.2274 | $17.63 | $18.51 | $17.63 | 38,162 | 3,260 | 8.54% |
12-23-2020 | $19.14 | $18.32 | $19.14 | $18.1824 | 27,103 | 2,860 | 10.55% |
12-22-2020 | $19.5 | $19.14 | $19.53 | $18.49 | 26,789 | 2,364 | 8.82% |
12-21-2020 | $19.68 | $19.42 | $19.8 | $19.15 | 49,225 | 2,804 | 5.7% |
12-18-2020 | $19.8 | $19.95 | $21.83 | $19.8 | 143,339 | 29,271 | 20.42% |
News, Short Squeeze, Breakout and More Instantly...
Miragen Therapeutics Inc. Company Name:
MGEN Stock Symbol:
NASDAQ Market:
Miragen Therapeutics Inc. Website:
Jonathan Violin, Ph.D., M.B.A. appointed President, CEO and director Barrett Katz, M.D., M.B.A. joins Viridian as Chief Medical Officer Viridian is developing VRDN-001 and VRDN-002 for the treatment of thyroid eye disease Company recently licensed exc...
Company obtains exclusive rights to develop and commercialize antibody therapeutics targeting insulin-like growth factor-1 receptor (IGF-1R) using Xencor’s Xtend™ half-life extension technology miRagen expects to file an Investigational New Drug (IND) application for VRD...
Recently completed acquisition of Viridian Therapeutics, including an anti-IGF-1R monoclonal antibody, VRDN-001, for the potential treatment of thyroid eye disease (TED) Private placement financing proceeds of approximately $91 million positions miRagen to potentially advance mult...